Clinical: An initial clinical study assessed the antidepressant efficacy of IN-NPY in stable MDD patients (also on conventional antidepressants), based upon preclinical studies assessing IN-NPY in post-traumatic stress disorder (PTSD) models. The gene discussed is NPY; the disease is post-traumatic stress disorder.